scholarly journals Inter-tumor heterogeneity of PD-L1 status: is it important in clinical decision making?

2020 ◽  
Vol 12 (5) ◽  
pp. 1770-1775
Author(s):  
Kenichi Suda ◽  
Tetsuya Mitsudomi
Cancers ◽  
2021 ◽  
Vol 13 (5) ◽  
pp. 973
Author(s):  
Bogdan Badic ◽  
Florent Tixier ◽  
Catherine Cheze Le Rest ◽  
Mathieu Hatt ◽  
Dimitris Visvikis

The steady improvement of high-throughput technologies greatly facilitates the implementation of personalized precision medicine. Characterization of tumor heterogeneity through image-derived features—radiomics and genetic profile modifications—genomics, is a rapidly evolving field known as radiogenomics. Various radiogenomics studies have been dedicated to colorectal cancer so far, highlighting the potential of these approaches to enhance clinical decision-making. In this review, a general outline of colorectal radiogenomics literature is provided, discussing the current limitations and suggested further developments.


2011 ◽  
Vol 20 (4) ◽  
pp. 121-123
Author(s):  
Jeri A. Logemann

Evidence-based practice requires astute clinicians to blend our best clinical judgment with the best available external evidence and the patient's own values and expectations. Sometimes, we value one more than another during clinical decision-making, though it is never wise to do so, and sometimes other factors that we are unaware of produce unanticipated clinical outcomes. Sometimes, we feel very strongly about one clinical method or another, and hopefully that belief is founded in evidence. Some beliefs, however, are not founded in evidence. The sound use of evidence is the best way to navigate the debates within our field of practice.


Sign in / Sign up

Export Citation Format

Share Document